JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A3924 Voreloxin

Summary: Topo II inhibitor

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
A3925 Voreloxin Hydrochloride

Summary: Antineoplastic naphthyridine analogue

Soluble in DMSO
A3926 Vortioxetine

Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT

Summary: 5-HT receptors antagonist

insoluble in H2O; ≥14.92 mg/mL
A3927 VS-5584 (SB2343)

Target: PI3K|mTOR

Summary: MTOR/P13K inhibitor,potent and selective

insoluble in H2O; ≥17.7 mg/mL
A3931 VX-11e
5 Citation

Target: ERK

Summary: ERK inhibitor

≥25 mg/mL
A3932 WAY 316606
1 Citation

Summary: sFRP-1 inhibitor

≥44.8 mg/mL
A3933 WAY-100635

Summary: 5-HT1A receptor antagonist,potent and selective

≥42.3 mg/mL
A3935 WEHI-539
15 Citation

Target: Bcl-xl

Summary: Bcl-xL inhibitor,potent and selective

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A3936 WHI-P97

Summary: Janus kinase (JAK)-3 inhibitor

Soluble in DMSO
A3937 XL019

Target: JAK

Summary: JAK2 inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥11.125 mg/mL